• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exploring the effects of glucagon-like peptide-1 receptor agonists on ventricular arrhythmias: a propensity score-matched analysis.

作者信息

Tan Min Choon, Vignarajah Aravinthan, Yeo Yong Hao, Lee Justin Z, Russo Andrea M, Scott Luis R, Sorajja Dan

机构信息

Department of Cardiovascular Medicine, Mayo Clinic Arizona, 5777 East Mayo Boulevard, Phoenix, Arizona 85054, USA.

Department of Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH, USA.

出版信息

Europace. 2025 May 7;27(5). doi: 10.1093/europace/euaf090.

DOI:10.1093/europace/euaf090
PMID:40314211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12096155/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/12096155/ca7bf445a0b5/euaf090_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/12096155/ca7bf445a0b5/euaf090_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a66/12096155/ca7bf445a0b5/euaf090_ga.jpg

相似文献

1
Exploring the effects of glucagon-like peptide-1 receptor agonists on ventricular arrhythmias: a propensity score-matched analysis.探索胰高血糖素样肽-1受体激动剂对室性心律失常的影响：一项倾向评分匹配分析。
Europace. 2025 May 7;27(5). doi: 10.1093/europace/euaf090.
2
Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.胰高血糖素样肽-1激动剂对肥胖合并肥厚型心肌病患者心血管结局的影响
Int J Cardiol. 2025 May 1;426:133082. doi: 10.1016/j.ijcard.2025.133082. Epub 2025 Feb 19.
3
Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1).GLP-1（胰高血糖素样肽-1）对心脏心室兴奋性的调制。
Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006740. doi: 10.1161/CIRCEP.118.006740.
4
Glucagon-Like Peptide-1 Receptor Agonist Use Is Not Associated With Increased Complications After Total Hip Arthroplasty in Patients Who Have Type 2 Diabetes.胰高血糖素样肽-1受体激动剂的使用与2型糖尿病患者全髋关节置换术后并发症增加无关。
J Arthroplasty. 2025 Jun;40(6):1413-1418.e1. doi: 10.1016/j.arth.2024.10.099. Epub 2024 Oct 30.
5
Glucagon-like peptide-1 receptor agonist use is associated with increased risk of perioperative complication and readmission following shoulder arthroplasty.胰高血糖素样肽-1受体激动剂的使用与肩关节置换术后围手术期并发症和再入院风险增加有关。
J Shoulder Elbow Surg. 2025 May;34(5):1152-1157. doi: 10.1016/j.jse.2024.09.012. Epub 2024 Nov 9.
6
Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study.胰高血糖素样肽-1受体激动剂与阿司匹林联合应用于有或无2型糖尿病的肥胖个体时意外的心血管风险：一项倾向评分匹配队列研究。
Diabetes Obes Metab. 2025 Apr;27(4):1980-1991. doi: 10.1111/dom.16191. Epub 2025 Jan 13.
7
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation.GLP-1RA 对导管消融后心房颤动复发的影响。
JACC Clin Electrophysiol. 2024 Aug;10(8):1848-1855. doi: 10.1016/j.jacep.2024.03.031. Epub 2024 May 22.
8
Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias.评估胰高血糖素样肽-1 受体激动剂对主要心脏心律失常影响的心血管结局试验的荟萃分析。
Acta Cardiol. 2023 Jul;78(5):519-524. doi: 10.1080/00015385.2022.2087839. Epub 2022 Jun 14.
9
Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.胰高血糖素样肽-1受体激动剂与胰腺癌风险：利用真实世界数据进行目标试验模拟
J Natl Cancer Inst. 2025 Mar 1;117(3):476-485. doi: 10.1093/jnci/djae260.
10
Fusion Outcomes of GLP-1 Agonist Therapy in Multilevel Cervical Spinal Fusion: A Propensity-Matched Analysis.胰高血糖素样肽-1激动剂疗法在多节段颈椎融合术中的融合结果：一项倾向评分匹配分析
Clin Spine Surg. 2025 May 1;38(4):213-216. doi: 10.1097/BSD.0000000000001775. Epub 2025 Mar 5.

本文引用的文献

1
Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC-endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society.管理电风暴或簇发性室性心律失常患者：欧洲心脏病学会心律协会的临床共识声明——由亚太心律学会、心律学会和拉丁美洲心律学会认可。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae049.
2
Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward.25 年的心室性心动过速导管消融治疗：回顾与展望。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad225.
3
Risk stratification of sudden cardiac death: a review.
心脏性猝死的风险分层：综述。
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad203.
4
Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects.聚焦 2022 ESC 指南：室性心律失常的管理和心源性猝死的预防：10 个新的关键方面。
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad091.
5
Modulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1).GLP-1（胰高血糖素样肽-1）对心脏心室兴奋性的调制。
Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006740. doi: 10.1161/CIRCEP.118.006740.
6
Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010.院外心脏骤停监测 - 心脏骤停注册以提高存活率 (CARES)，美国，2005 年 10 月 1 日至 2010 年 12 月 31 日。
MMWR Surveill Summ. 2011 Jul 29;60(8):1-19.